Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Mar 04, 2019

SELL
$33.0 - $60.04 $137,676 - $250,486
-4,172 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$56.15 - $73.9 $151,492 - $199,382
-2,698 Reduced 39.27%
4,172 $257,000
Q2 2018

Aug 06, 2018

SELL
$47.85 - $70.45 $1,579 - $2,324
-33 Reduced 0.48%
6,870 $464,000
Q1 2018

May 08, 2018

SELL
$51.15 - $61.0 $175,495 - $209,291
-3,431 Reduced 33.2%
6,903 $374,000
Q4 2017

Feb 06, 2018

BUY
$50.85 - $65.1 $525,483 - $672,743
10,334
10,334 $617,000

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.